Indeed, the use of these or similar exclusion criteria assured, as shown in several RCTs, large case series and systematic review, 1–3 , 5 , 7 , 14–16 , 36 the occurrence of no or few adverse events related to the infusion of donors' material, as also stated in the French National Guidelines of FMT for the treatment of rCDI.